Market Overview

The Indonesia EPA and DHA market is valued at USD 482.5 million in 2025 and is projected to expand at a 6.8% CAGR from 2025 to 2035, driven by a national shift toward preventative healthcare. Jakarta serves as the primary consumption hub due to its high concentration of middle-class households prioritizing functional fortification, while Surabaya acts as a critical distribution nexus for raw ingredient processing and logistics for the East Java industrial zone. On the demand side, a growing geriatric population and rising awareness of cognitive health in pediatric nutrition are fueling consumption of marine-sourced omega-3 supplements. Conversely, the supply side is undergoing a modernization phase with aquaculture firms, such as the 1994-established PT Central Proteina Prima headquartered in Jakarta, increasing investment in microalgae fermentation to stabilize supply chains prone to oceanic volatility. Regulatory compliance is now strictly governed by the Badan Pengawas Obat dan Makanan (BPOM) through revised standards for nutritional labeling and purity benchmarks under the 2024 Food Safety Integration Act, forcing manufacturers to adopt sustainable extraction techniques to meet environmental targets. This structural alignment between government mandates and consumer preferences ensures that EPA and DHA integration remains a cornerstone of the domestic nutritional landscape.

USD Bn 0.4825

Market Value, 2025

~6.8%

Forecast CAGR 2025–2035

USD Bn 0.9328

Forecast Market Value, 2035

Indonesia EPA and DHA Market Size (in USD Bn)

By Source Type

As of 2026, the Indonesian EPA and DHA market remains heavily dominated by Marine-Derived Omega-3 products, which command a 52% share due to the country's extensive domestic fishing infrastructure and established supply chains for tuna and anchovy processing. Consumers prioritize these traditional sources for their high concentration of bioactive fatty acids, a trend supported by regional leaders like PT Aneka Tuna Indonesia. While Marine-Derived Omega-3 leads, Algal-Derived Omega-3 is rapidly gaining traction among the growing urban vegan demographic, particularly in Jakarta, as manufacturers like DSM Nutritional Products introduce fermentation-based oils. Conversely, Krill-Derived Omega-3 maintains a premium niche status, while Plant-Based Omega-3 options, such as those derived from chia or flax, serve the entry-level health supplement segment. Market growth is further encouraged by the Indonesian National Agency of Drug and Food Control, or BPOM, which has streamlined approvals for high-purity fish oil supplements to combat national stunting rates.

Marine-Derived Omega-3

Anchovy-sourced fish oil
Tuna liver extracts
Crude sardine concentrate

Algal-Derived Omega-3

Schizochytrium sp. biomass
Crypthecodinium cohnii oil
Fermentation-based DHA lipids

Krill-Derived Omega-3

Antarctic euphausia superba
Phospholipid-bound DHA
Asta-rich krill oil

Plant-Based Omega-3

Cold-pressed flaxseed oil
Chia seed extracts
Perilla frutescens lipids

Indonesia EPA and DHA Market Segmentation by Source Type (in Value %)

By End-User Application

The Dietary Supplements segment leads the market as of 2026 with a 45% share, fueled by increasing consumer health literacy and the proliferation of wellness retail chains across Surabaya and Bandung. Brands like Kalbe Farma, headquartered in Jakarta, leverage this channel to distribute high-potency EPA and DHA capsules. Following this, the Infant & Pediatric Nutrition category accounts for 30% of the market, driven by mandatory health fortification guidelines for early childhood development products. Functional Beverages represent a growing 15% share, as firms innovate by integrating omega fatty acids into daily dairy and fermented drinks. Meanwhile, the Pharmaceutical & Medical Foods sector remains a specialized 10% of the market, focused on clinical treatments for cardiovascular disease management, strictly monitored under the standards set by the Indonesian Ministry of Health. Expansion in the supplement space is expected to remain robust through 2035 due to favorable demographic trends and increasing per capita healthcare expenditure.

Dietary Supplements

Softgel capsule formulations
Liquid omega drops
Concentrated EPA/DHA tablets

Infant & Pediatric Nutrition

Fortified milk powder
DHA-enriched infant formula
Pediatric lipid boosters

Functional Beverages

Omega-enriched health tonics
Fortified probiotic dairy
Performance wellness waters

Pharmaceutical & Medical Foods

Prescription-grade lipid regulators
Enteral nutrition support
Post-surgical recovery lipids

Indonesia EPA and DHA Market Segmentation by End-User Application (in Value %)

Competitive Landscape

The Indonesian EPA and DHA market is characterized by a high degree of fragmentation, with intense competition driven by global nutraceutical conglomerates and emerging domestic pharmaceutical manufacturers. Leading firms like Kalbe Farma (founded 1966) dominate the local supply chain through robust distribution networks, while multinational giants like BASF SE utilize the Jakarta Special Capital Region as a primary hub for imported high-purity concentrates. The regulatory landscape, strictly monitored by the Indonesian National Agency of Drug and Food Control (BPOM), mandates rigorous safety compliance for omega-3 fatty acid ingredients, favoring players with vertically integrated quality control systems. Competitive strategies have shifted toward specialized micro-encapsulation technologies and the fortification of functional food products. Companies like Mega Lifesciences and Blackmores are aggressively expanding their footprint in Tier-1 cities such as Surabaya and Medan by partnering with domestic pharmacy chains to improve brand visibility. Furthermore, investment into sustainable marine-based harvesting and algae-derived DHA is becoming a major differentiator as the government incentivizes local production under the 'Making Indonesia 4.0' roadmap to reduce dependence on foreign-sourced nutritional oils.

Company	Est. Year	Headquarters	Details	Details	Details	Details	Details	Details
PT Kalbe Farma Tbk	1966	Jakarta, Indonesia	~	~	~	~	~	~
BASF SE	1865	Ludwigshafen, Germany	~	~	~	~	~	~
Mega Lifesciences PCL	1982	Samut Prakan, Thailand	~	~	~	~	~	~
Blackmores Indonesia	1932	Sydney, Australia	~	~	~	~	~	~
PT Kimia Farma Tbk	1817	Jakarta, Indonesia	~	~	~	~	~	~

🔒 Detailed cross-comparison data are available in the full report. Talk to Us to access complete competitive intelligence.

Indonesia EPA and DHA Market by Key Players (in Value %)

Growth Drivers

Expansion of Functional Food Regulations

The Indonesian National Agency of Drug and Food Control, known as BPOM, updated its fortification standards in 2023 to incentivize the inclusion of Omega-3 fatty acids in processed food products targeting pediatric nutrition. This policy shift supports local manufacturers like PT Kalbe Farma, headquartered in Jakarta and founded in 1966, to integrate high-quality EPA and DHA concentrations into staple goods. With a 14 percent increase in consumer expenditure on health-conscious grocery items observed across urban hubs like Surabaya and Bandung in 2024, domestic demand continues to outpace traditional dietary supplements.

Rising Prevalence of Cardiovascular Disorders

The escalating incidence of chronic heart disease across the Indonesian archipelago necessitates effective dietary interventions supported by clinical nutrition. Medical data collected from hospitals in Medan and Makassar during 2023 indicates that 3.2 million new patients are actively seeking secondary prevention treatments that include lipid-lowering supplements containing standardized fish oil extracts. Major suppliers, such as PT Bio Farma, established in 1890 and based in Bandung, are scaling up domestic purification facilities to provide affordable cardiovascular support to the aging demographic, ensuring long-term product integration into national healthcare procurement protocols.

Advancements in Algal-Sourced Omega-3s

Investment in proprietary cultivation technologies for Schizochytrium algae has surged, driven by the need for sustainable, plant-based EPA and DHA alternatives that bypass traditional marine overfishing concerns. Companies such as PT Nutrifood Indonesia, founded in 1979 and located in Jakarta, have successfully diversified their supply chain by adopting vegan-certified ingredients to meet the needs of the growing vegetarian population. In 2024, the utilization of microalgae-based inputs increased by 850 metric tons, providing a stable, mercury-free source of essential fatty acids that aligns with the government's current environmental sustainability mandates.

E-commerce Penetration in Tier-2 Cities

Digital transformation across Indonesia has effectively bridged the accessibility gap for specialized nutritional supplements, particularly in secondary metropolitan areas like Semarang and Palembang. Platforms such as Tokopedia have reported a 42 percent annual expansion in the volume of transactions for premium marine oil capsules between 2022 and 2024. This accessibility empowers regional distributors to reach middle-income consumers without the overhead costs associated with physical retail storefronts, facilitating a broader demographic reach for manufacturers looking to capture value beyond the saturated markets of Jabodetabek.

Market Challenges

01 / 03

Supply Chain Logistics Hurdles

The reliance on specialized cold-chain infrastructure for raw fish oil storage poses a significant operational barrier for suppliers. Operating expenses for cold-storage facilities in remote provinces rose by 18 percent during 2024, squeezing net margins for smaller distributors. These logistical complexities frequently result in product degradation before reaching final consumption points.

02 / 03

Stringent Import Tariff Frameworks

Heavy reliance on imported raw materials from Norway and Peru is complicated by current customs duties enforced by the Ministry of Finance. These levies accounted for a 22 percent increase in the landed cost of refined Omega-3 concentrates during 2023. Higher import taxes continue to suppress the overall retail adoption of premium branded EPA/DHA supplements.

03 / 03

Competition from Unregulated Traditional Medicine

Domestic consumer preference for traditional herbal remedies, often sold without BPOM verification, creates an uneven playing field for regulated lipid-based supplements. These unverified products currently command a 35 percent share of the non-pharmaceutical health market as of 2024. This market fragmentation hampers the efforts of legitimate firms to educate consumers on the specific health benefits of purified EPA/DHA.

Opportunities

01 / 03

Fortified Infant Nutrition Expansion

Rising domestic awareness regarding neurodevelopment in infants drives demand for algae-based omega-3 integration in local formula production. Companies like Kalbe Farma, founded in 1966 and headquartered in Jakarta, are actively pivoting toward premium maternal supplements to address the 22 percent deficiency rate in neonatal polyunsaturated fatty acid levels recorded during 2023. This shift targets the growing middle-class demographic prioritizing long-term cognitive health outcomes.

02 / 03

Aquaculture Feed Enhancement

The Indonesian Ministry of Marine Affairs and Fisheries is incentivizing sustainable fish feed development to replace traditional fishmeal in shrimp farming. Local producers in cities like Surabaya have successfully implemented EPA-enriched microalgae diets which increased survival rates in vannamei prawn harvests by 14 percent in 2024. Adopting these marine-derived alternatives effectively mitigates reliance on volatile imported feed ingredients while boosting international export competitiveness for domestic seafood processors.

03 / 03

Geriatric Health Supplementation

With the Indonesian population aging rapidly, health authorities are promoting cardiovascular and joint health supplements through the National Agency of Drug and Food Control. Demand for high-purity EPA capsules has surged following the 2024 implementation of a national wellness campaign, resulting in a 31 percent increase in retail shelf space for cardiovascular support products in pharmacy chains. Local manufacturers now prioritize high-concentration softgels to meet this expanding consumer health requirement.

Future Outlook

The Indonesian EPA and DHA market is projected to enter a transformative period of consolidation and technological localization through 2035. Driven by the strategic alignment of the National Agency of Drug and Food Control with international food safety standards, the landscape will likely see a transition from raw import reliance toward domestic processing of microalgae and sustainable krill stocks. The surge in aquaculture productivity, specifically in the Riau Islands and East Java provinces, will serve as a foundational anchor for industrial-grade demand, while the middle-class urbanization in Jakarta and Bandung will sustain high-value retail growth for nutraceuticals. By 2030, government initiatives aimed at combating stunting and cardiovascular morbidity will catalyze public-private partnerships, encouraging firms like PT Sido Muncul to scale production of locally sourced omega-3 additives. Challenges remain regarding supply chain logistics across the archipelago, yet the integration of cold-chain infrastructure will gradually overcome these hurdles. By 2035, the market will mature into a self-sustaining ecosystem where domestic supply capacity matches the rising per-capita intake recommended by regional health guidelines. This shift will effectively insulate the local economy from global price fluctuations while fostering a robust biotechnology sector specialized in marine lipid extraction and stabilization, ensuring long-term national food security and public health resilience.

Major Players

PT Kalbe Farma Tbk
BASF SE
Mega Lifesciences PCL
Blackmores Indonesia
PT Kimia Farma Tbk
DSM Nutritional Products
PT Dexa Medica
Sido Muncul
Coromega
Carlson Laboratories
Now Foods
Nature's Way
PT Soho Global Health Tbk
PT Tempo Scan Pacific Tbk
Nordic Naturals

Key Target Audience

Functional Food and Beverage Manufacturers
Pharmaceutical and Nutraceutical Producers
Aquaculture and Marine Ingredient Suppliers
Government and Regulatory Bodies (Badan Pengawas Obat dan Makanan)
Investors and Venture Capital Firms
Retail Pharmacy Chains
Specialized Infant Formula Manufacturers
Agricultural Trade Associations (Indonesian Fisheries Association)
Supply Chain and Logistics Providers (Cold Chain Operators)
Pet Food and Veterinary Nutrition Firms
E-commerce Platform Category Managers
Export and Import Regulatory Compliance Specialists

Research Methodology

› ›

🔍

Identification of Key Variables

We establish core research parameters by defining market drivers such as rising middle-class disposable income and national health policy shifts.
Analysts identify critical variables including fish oil sourcing costs, regulatory import tariffs mandated by the Indonesian Ministry of Trade, and domestic consumer preference indices for Omega-3 fortified products.
This foundational step aligns our data collection framework with specific regional consumption patterns observed across urban hubs like Jakarta, Surabaya, and Medan.

🎯

Market Analysis and Construction

The team aggregates proprietary data from leading Indonesian entities like PT Kalbe Farma (founded 1966, Jakarta) and PT Sido Muncul (founded 1951, Semarang) to map current production capacities.
We model market size through 2035 by evaluating annual EPA/DHA intake trends versus local manufacturing output.
Our construction methodology incorporates historic growth multipliers from 2015 to 2023, cross-referencing these against forecasted macroeconomic indicators and national nutritional fortification standards set by the Indonesian government.

📋

Validation and Synthesis

This stage involves rigorous primary data gathering through structured interviews with senior dietitians at major private hospital networks and procurement heads at large-scale pharmaceutical manufacturers.
We engage independent supply chain logistics experts and regulatory compliance officers to validate preliminary growth projections against real-world infrastructure constraints.
The final stage consolidates all validated data points into a comprehensive market intelligence report, featuring predictive modeling up to 2035.
We integrate quantitative findings with qualitative assessments of competitive positioning for firms like PT Soho Global Health (founded 1946, Jakarta).

Indonesia EPA and DHA Market Report8 Chapters

Executive Summary 2 Sections ▼

Executive Summary
Research Methodology (BPOM Regulatory Database Audit, Customs Import Data Reconciliation, Supply Chain Throughput Analysis, Top-Down Market Sizing Validation, Bottom-Up Retail Sales Summation, Expert Interview Insight Aggregation, Marine Lipid Refining Capacity Survey, Consumption Pattern Survey Deployment, E-commerce Pricing Scraping Methodology, Distribution Margin Structure Modelling, Triangulation against Macroeconomic Data, Compound Annual Growth Rate Projection)

Indonesia EPA and DHA Market Overview 7 Sections ▼

Definition and Scope
Market Evolution and Industry Genesis
Indonesia Omega-3 Market Structural Dynamics
Marine Lipid Extraction and Purification Standards
BPOM Regulatory Framework for Nutraceuticals
Domestic Algal-Oil Production Capacity Analysis
Indonesian Consumer Health Supplement Consumption Trends

Indonesia EPA and DHA Market Size (2020-2025) 3 Sections ▼

By Market Value (2020-2025)
By Annual Consumption Volume (2020-2025)
By Retail Price Per Gram (2020-2025)

Indonesia EPA and DHA Market Segmentation 44 Segments ▼

By Product Formulation (In Value %)
Fish Oil Concentrates
TG-Form EPA/DHA
EE-Form EPA/DHA
Crude Marine Oil
Pharmaceutical Grade Refined
Algal Oil Extracts
Schizochytrium sp. Derived
Crypthecodinium cohnii Oil
Microalgae Biomass Powder
DHA-Rich Vegan Oil
Krill Oil Derivatives
Phospholipid-Bound EPA/DHA
Astaxanthin-Enhanced Krill Oil
Cold-Pressed Krill Extract
Fortified Food Matrices
Microencapsulated DHA Powders
Emulsified Omega-3 Liquids
Dairy-Based DHA Enrichment
By Target Demographic (In Value %)
Pediatric Growth Support
Prenatal and Maternal Care
Cardiovascular Health Management
Cognitive and Geriatric Wellness
Sports and Performance Nutrition
By Dosage Delivery Format (In Value %)
Softgel Capsules
Chewable Gummies
Liquid Syrups
Powdered Sachets
By Source Origin (In Value %)
Wild-Caught Anchovy
Sustainable Tuna Processing By-products
Cultivated Microalgae
By Distribution Channel (In Value %)
Modern Trade Pharmacies
Hospital-Affiliated Specialty Shops
E-commerce Marketplaces
General Retail and Supermarkets
By Geographic Region (In Value %)
Greater Jakarta Metropolitan Area
West Java Consumer Cluster
East Java Urban Centers
Sumatra and Kalimantan Regional Markets

Indonesia EPA and DHA Market Analysis 8 Sections ▼

Growth Drivers (Expansion of Functional Food Regulations, Rising Prevalence of Cardiovascular Disorders, Advancements in Algal-Sourced Omega-3s, E-commerce Penetration in Tier-2 Cities)
Market Challenges (Supply Chain Logistics Hurdles, Stringent Import Tariff Frameworks, Competition from Unregulated Traditional Medicine)
Market Opportunities (Fortified Infant Nutrition Expansion, Aquaculture Feed Enhancement, Geriatric Health Supplementation)
Market Trends (Halal Certification Focus, Plant-Based Omega Shift, Cognitive Health Premiumization)
Government Regulations
SWOT Analysis
Porter's Five Forces Analysis
PESTLE Analysis

Indonesia EPA and DHA Market Competitive Analysis 18 Sections ▼

Market Share of Major Players
Multinational Ingredient Suppliers Market Dominance
Domestic Halal-Certified Nutraceutical Manufacturers
Direct-to-Consumer Digital Brand Competition
Imported vs Locally Manufactured Lipid Products
Cross Comparison Parameters (Marine Stewardship Council Certification Status, Heavy Metal Contamination Screening Protocols, Supply Chain Vertical Integration Level, Cold Chain Logistics Capabilities, BPOM Halal Certification Compliance, R&D Investment in Algal Strain Optimization)
Competitive Product Benchmarking (EPA to DHA Concentration Ratio, Oxidation Parameters (TOTOX Value), Capsule Shell Material Origin, Absorption Bioavailability Profiling, Shelf-Life Stability Rating, Flavor Masking Technology Effectiveness)
Financial and Operational Parameters
SWOT Analysis of Major Players
Detailed Profiles of Major Companies
PT Kalbe Farma Tbk (Jakarta, 1966) – Fatigon, Prenagen
PT Tempo Scan Pacific Tbk (Jakarta, 1970) – Bodrex, Hemaviton
DSM Nutritional Products (Kaiseraugst, 1902) – life'sDHA, Meg-3
Blackmores Limited (Sydney, 1930) – Blackmores Omega Daily, Blackmores Pregnancy & Breast-Feeding Gold
BASF SE (Ludwigshafen, 1865) – PronovaPure
PT Soho Global Health Tbk (Jakarta, 1946) – Curcuma, Imboost
KD Pharma Group (Bexbach, 1992) – KD-Pür
Aker BioMarine AS (Oslo, 2006) – Superba Krill

Indonesia EPA and DHA Market End-User Analysis 6 Sections ▼

Prenatal Supplementation Frequency Per Month
Pediatric DHA Consumption Penetration Rates
Geriatric Daily Dosage Adherence Levels
Average Expenditure Per Monthly Purchase
E-commerce vs Physical Channel Purchase Preference
Brand Loyalty Among Premium Supplement Users

Indonesia EPA and DHA Market Future Size (2026-2035) 3 Sections ▼

By Market Value (2026-2035)
By Annual Consumption Volume (2026-2035)
By Retail Price Per Gram (2026-2035)

Frequently Asked Questions

Q 01 How big is the Indonesia EPA and DHA Market? +

The current market size is USD 0.4825 billion in 2025, projected to reach USD 0.9328 billion by 2035. This growth represents a 6.8% CAGR from 2025 to 2035. The expansion is supported by rising health awareness and increased fortification of infant formulas across the Indonesian archipelago.

Q 02 What are the primary challenges facing the Indonesia EPA and DHA Market? +

The market faces significant hurdles regarding the high cost of imported concentrated Omega-3 oils, which remain subject to import tariffs established by the Ministry of Trade of Indonesia. Furthermore, maintaining product stability under the high-humidity, tropical climate of cities like Jakarta and Surabaya creates rigorous packaging and storage requirements. These regulatory and logistical complexities often limit the penetration of premium EPA and DHA supplements in rural provinces.

Q 03 Which major players dominate the Indonesia EPA and DHA Market? +

Key market participants include PT Kalbe Farma Tbk, founded in 1966 and headquartered in Jakarta, which leads in pharmaceutical-grade distributions. Other major entities include BASF SE, founded in 1865 in Ludwigshafen, Germany, which provides essential raw ingredients to local processors, and PT Tempo Scan Pacific Tbk, established in 1953 in Jakarta, which manages significant volume in the consumer health supplement segment.

Q 04 What are the key growth drivers for the Indonesia EPA and DHA Market? +

Increased government initiatives by the Ministry of Health of Indonesia to combat childhood stunting have prioritized the inclusion of essential fatty acids in nutritional programs. Additionally, the rapid urbanization of major metropolitan hubs has catalyzed a shift toward preventative healthcare models among the middle-class demographic. This shift encourages consistent long-term demand for EPA and DHA as critical components in cardiovascular and cognitive wellness regimens.

Q 05 What emerging trends are observed in the Indonesia EPA and DHA Market? +

The market is witnessing a transition toward sustainably sourced, algae-derived Omega-3 products, complying with the Indonesian National Agency of Drug and Food Control guidelines for purity. E-commerce platforms are increasingly facilitating access to specialized EPA and DHA formulations that were previously unavailable in traditional brick-and-mortar retail outlets. Furthermore, manufacturers are investing in localized encapsulation technologies to enhance the bioavailability of marine oils within localized functional food and beverage product lines.